FMTVDM Study Proposal: WID2H - Breast Trial. (Weight, Inflammation, Diet v Drug, Heart disease) – Breast Trial

Main Article Content

Richard M Fleming*
Matthew R Fleming
William C Dooley

Downloads

Download data is not yet available.

Article Details

Fleming, R. M., Fleming, M. R., & Dooley, W. C. (2020). FMTVDM Study Proposal: WID2H - Breast Trial. (Weight, Inflammation, Diet v Drug, Heart disease) – Breast Trial. Journal of Cardiovascular Medicine and Cardiology, 7(2), 072–078. https://doi.org/10.17352/2455-2976.000116
Research Article(s)

Copyright (c) 2020 Fleming RM, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Inflammation and Heart Disease; Fleming Unified Theory of Vascular Disease. 1-655833842. Started 9-1-2011. Effective 9-16-2011, TX 7-451-244.

Fleming RM (1999) Chapter 64. The Pathogenesis of Vascular Disease. Textbook of Angiology. John C. Chang Editor, Springer-Verlag New York, NY 787-798. Link: https://bit.ly/3bC2iiF

Fleming RM (2000) The Fleming Unified Theory of Vascular Disease: A Link Between Atherosclerosis, Inflammation, and Bacterially Aggravated Atherosclerosis (BAA). Angiol 51: 87-89. Link: https://bit.ly/2VpZy1Y

Fleming RM, Boyd L, Forster M (2000) Reversing Heart Disease in the New Millennium - The Fleming Unified Theory. Angiology 51: 617-629. Link: https://bit.ly/2XR6mHF

Fleming RM (2003) Angina and coronary Ischemia are the result of coronary regional Blood Flow Differences. J Amer Coll Angiol 1:127-142.

Stenosis Flow Reserve (SFR), Coronary Flow Reserve (CFR); Quadratic Coronary Flow Reserve (QCFR). 1-655833951. Started 9-1-2011.

Fleming RM (1999) Chapter 29. Atherosclerosis: Understanding the relationship between coronary artery disease and stenosis flow reserve. Textbook of Angiology. John C. Chang Editor, Springer-Verlag, New York, NY 381-387.

Fleming RM, Fleming MR, Chaudhuri TK (2019) True AI Implementation Through FMTVDM Proprietary Equations and QCA. Biomed J Sci Tech Res 20: 15154-15160. Link: https://bit.ly/2zjoaRx

Fleming RM, Harrington GM (2008) "What is the Relationship between Myocardial Perfusion Imaging and Coronary Artery Disease Risk Factors and Markers of Inflammation?" Angiology 59: 16-25. Link: https://bit.ly/3ezuzYS

Matthew R (2000) Storks Deliver Babies (p=0.008). Teaching Statistics 22: 36-38. Link: https://bit.ly/3eDqwuz

Fleming RM (1999) Chapter 31. Nuclear Cardiology: Its Role in the Detection and Management of Coronary Artery Disease Textbook of Angiology. John C. Chang Editor, Springer-Verlag New York, NY 397-406.

The Fleming Method for Tissue and Vascular Differentiation and Metabolism (FMTVDM) using same state single or sequential quantification comparisons. Patent Number 9566037.

Fleming RM, Fleming MR, McKusick A, Chaudhuri TK (2018) Semi-quantification limitations: FMTVDM©℗ demonstrates quantified tumor response to treatment with both regional blood flow and metabolic changes. J Nucl Med 59: 1643-1644. Link: https://bit.ly/2VndyJK

Fleming RM, Fleming MR, McKusick A, Chaudhuri T (2018) FMTVDM-TFM©℗: True Quantification requires Standardization of the tool being used to Measure, with a Known, Unchanging Standard to produce accurate, consistent and reproducible Quantified Measurements. J Nucl Card 26. Link: https://bit.ly/34PjFK8

Fleming RM, Fleming MR, Chaudhuri TK (2019) True AI Implementation Through FMTVDM Proprietary Equations and QCA. Biomed J Sci Tech Res 20: 15154-15160. Link: https://bit.ly/3eAA3CB

Fleming RM, Fleming MR, Harrington G, McKusick A, Chaudhuri T (2018) USVAH Study demonstrates statistically significant improvement in diagnosis and care of U.S. Veterans using FMTVDM-FHRWW ©℗ “Quantitative” Nuclear Imaging. The era of truly quantitative stress-first, stress-only imaging has begun! J Nucl Med Radiat Ther 9: 006. Link: https://bit.ly/2KnHHCG

Fleming RM, Fleming MR, McKusick A, Chaudhuri T (2018) Multi Center Clinical Trial Confirms FMTVDM©℗ MPI in Seven Modern Clinical Laboratories in the U.S.A. and Asia. Artificial Intelligence (AI) with True Quantification. J Nucl Med Radiat Ther 9: 372. Link: https://bit.ly/34TY0Ah

Fleming RM, Fleming MR, Chaudhuri TK, McKusick A (2019) FMTVDM provides first patented Quantitative Method to accurately Measure both Heart Disease and Breast Cancer on the “Health-Spectrum”. J Cardiovasc Med Cardiol 6: 019-020. Link: https://bit.ly/2VqddG8

Glagov s, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory Enlargement of Human Atherosclerotic Coronary Arteries. N Engl J Med 316: 1371-1375. Link: https://bit.ly/2yx2ZuC

Fleming RM, Kirkeeide RL, Smalling RW, Gould KL (1991) Patterns in Visual Interpretation of Coronary Arteriograms as Detected by Quantitative Coronary Arteriography. J Am Coll Cardiol 18: 945- 951. Link: https://bit.ly/2VJzQEL

Fleming RM (2000) Shortcomings of coronary angiography. Letter to the Editor. Cleve Clin J Med 67: 450.

Fleming RM (2001) Coronary Artery Disease is More than Just Coronary Lumen Disease. Amer J Card 88: 599-600. Link: https://bit.ly/34QdXYg

Cancer Stat Facts: Common Cancer Sites. Link: https://bit.ly/2Vmf3YO

Ekpo EU, Alakhras M, Brennan P (2018) Errors in Mammography Cannot be Solved Through Technology Alone. Asian Pac J Cancer Prev 19: 291-301. Link: https://bit.ly/2RTGDdP

Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. et al. (2014) Twenty-five-year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ 348: g366. Link: https://bit.ly/3avYn5C

Krishna S, Murray CA, McInnes MD, Chatelain R, Siddaiah M, et al. (2017) CT imaging of solid renal masses: pitfalls and solutions. Clin Radiol 72: 708-721. Link: https://bit.ly/2VnYrjb

Rominger M, Berg D, Frauenfelder T, Ramaswamy A, Timmesfeld N, et al. (2016) Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer? Eur Radiol 26: 1457-1465. Link: https://bit.ly/2VG8uiG

Raab SS, Grzybicki DM, Janosky JE, Zarbo RJ, Meier FA, et al. (2005) Clinical Impact and Frequency of Anatomic Pathology Errors in Cancer Diagnosis. Cancer 104: 2205-2213. Link: https://bit.ly/3eF2UpB

Raab SS, Grzybicki DM (2010) Quality in cancer diagnosis. CA Cancer J Clin 60: 139-165. Link: https://bit.ly/3aqd3Dh

Tosteson ANA, Yang Q, Nelson HD, Longton G, Soneji SS, et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment and care costs. Breast Cancer Res Treat 167: 195-203. Link: https://bit.ly/34R51C5

Tucker I (2018) AI cancer detectors. Link: https://bit.ly/2VpxOe3

Fleming RM, Dooley WC, Chaudhuri TK (2017) The Development of FMTVDM-BEST Imaging: The Answer for Breast Cancer. Breast Enhanced Scintigraphy Test (BEST): Quantifying the Detection of Breast Cancer and its Treatment. J Nucl Med Radiat Ther 8: 350. Link: https://bit.ly/3eEmuCg

Sheikh A (2018) Evolution of Quantification in Clinical Nuclear Medicine: A Brief Overview of Salient Uses and Upcoming Trends. J Nucl Med Radiat Ther 9: 375. Link: https://bit.ly/2VrrFOu

Fleming RM, Fleming MR, Dooley WC, Chaudhuri TK (2020) The Importance of Differentiating Between Qualitative, Semi-Quantitative and Quantitative Imaging – Close Only Counts in Horseshoes. Eur J Nucl Med Mol Imaging 47: 753-755. Link: https://bit.ly/3an6Xn6

Fleming RM, Fleming MR, Chaudhuri TK, McKusick A (2019) Ethics in Medicine – The Hippocratic Oath! Acta Scientific Med Sci.

Wright GL, Maroulakou IG, Eldridge J, Liby TL, Sridharan V, et al. (2008) VEGT stimulation of mitochondrial biogenesis: requirement of AKT3 kinase. FASEB J 22: 3264-3275. Link: https://bit.ly/2xBG8OL

Siemerink MJ, Klaassen I, Vogels IMC, Griffioen AW, Van Noorden CJ, et al. (2012) CD34 marks angiogenic tip cells in human endothelial cell cultures. Angiogenesis 15: 151-163. Link: https://bit.ly/2wUSXTT

Senchukova MA, Nikitenko NV, Tomchuk ON, Zaitsev NV, Stadnikov AA (2015) Different types of tumor vessels in breast cancer: morphology and clinical value. Springerplus 4: 512. Link: https://bit.ly/2RQfF6M

Luengo-Gil G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, Chaves-Benito A, et al. (2018) Angiogenic role of miR-20a in breast cancer. PLoS ONE 13: e0194638. Link: https://bit.ly/2KlhNPR

Fleming RM, Fleming MR, Chaudhuri TK, McKusick A, Dooley WC (2019) Nuclear Imaging: Physician Confusion Over True Quantification and Isotope Redistribution. J Clin Cases Rep 3: 32-42. Link: https://bit.ly/3cx6gcc

Fleming RM, Dooley WC (2002) Breast Enhanced Scintigraphy Testing (B.E.S.T.) Distinguishes Between Normal, Inflammatory Breast Changes and Breast Cancer. A Prospective Analysis and Comparison with Mammography. Integr Cancer Ther 1: 238-245. Link: https://bit.ly/2wTCkb1

Fleming RM, Fleming MR, Chaudhuri TK, Dooley WC, McKusick A (2019) Letter to the Editor: A response to Hruska’s case study on molecular breast imaging and the need for true tissue quantification. Breast Cancer Res 21: 15. Link: https://bit.ly/2RUZapZ

Fleming RM, Fleming MR, Chaudhuri TK, McKusick A, Dooley WC (2019) Statistical demonstration that FMTVDM is superior to mammography. Ann Clin Radiol 2: 1012. Link: https://bit.ly/3cuYBLm

Fleming RM, Fleming MR (2019) Flawed evidence underpins approval of new cancer drugs. BMJ 366: l5399. Link: https://bit.ly/2XO0E9v